Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Limbal epithelial stem cell therapy.

Julie T Daniels1, Maria Notara, Alex J Shortt

  • 1UCL Institute of Ophthalmology, Cells for Sight Transplantation and Research Programme, Ocular Repair and Regeneration Biology Unit, Division of Pathology, London, EC1V 9EL, UK. j.daniels@ucl.ac.uk

Expert Opinion on Biological Therapy
|December 8, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Higher BMI is associated with greater fatigue and dyspnea in interstitial lung disease: a Pulmonary Fibrosis Foundation Registry study.

Annals of the American Thoracic Society·2026
Same author

Genetic Prediction of Keratoplasty in Fuchs Endothelial Corneal Dystrophy.

Ophthalmology·2026
Same author

Comment: What Else Could a Material History of Medicine Be?

Bulletin of the history of medicine·2026
Same author

Real Architecture for 3D Tissue (RAFT): Mechanical Properties and Ability to Support the 3D Culture of Porcine Corneal Endothelial Cells.

Journal of biomedical materials research. Part A·2026
Same author

Fetal ascites caused by ovarian incarceration within an inguinal hernia and development of maternal mirror syndrome.

BMJ case reports·2026
Same author

Genetic Structure and Migration Routes of <i>Phytophthora ramorum</i> into Ireland and Northern Ireland.

Phytopathology·2026
Same journal

TNF inhibitors for the long-term management of juvenile idiopathic arthritis associated uveitis: real-life data from the ITHACA cohort.

Expert opinion on biological therapy·2026
Same journal

Type 2 inflammation and biologics: a twenty-year journey.

Expert opinion on biological therapy·2026
Same journal

Current outlook on the use of biological agents to improve outcomes in adult secondary hemophagocytic lymphohistiocytosis.

Expert opinion on biological therapy·2026
Same journal

Addressing challenges in disease management of childhood-onset systemic lupus erythematosus: the role of biologics, with primary focus on rituximab and belimumab.

Expert opinion on biological therapy·2026
Same journal

Biological drugs for the treatment of children with atopic dermatitis.

Expert opinion on biological therapy·2026
Same journal

Optimizing biologic therapy in psoriasis: dose adjustment, treatment duration, and tapering-an expert perspective.

Expert opinion on biological therapy·2026
See all related articles

Limbal epithelial stem cell therapy can restore vision in patients with blinding eye diseases. This adult stem cell therapy is advancing research into stem cell biology and potential applications for other stem cell populations.

Area of Science:

  • Ophthalmology
  • Regenerative Medicine
  • Stem Cell Biology

Background:

  • Blinding ocular surface diseases were previously intractable.
  • Adult stem cell therapies are emerging in clinical practice.
  • Limbal epithelial stem cells (LESCs) offer a viable treatment option.

Purpose of the Study:

  • To highlight key research areas for understanding LESC biology.
  • To explore the therapeutic potential of LESCs.
  • To investigate applicability to other adult stem cell populations.

Main Methods:

  • Ex vivo expansion of LESCs.
  • Transplantation of expanded LESCs onto the cornea.
  • Review of current research in LESC biology and therapy.

Related Experiment Videos

Main Results:

  • Successful vision restoration in patients with ocular surface disease.
  • Established LESC transplantation as a clinical adult stem cell therapy.
  • Identified key research avenues for future advancements.

Conclusions:

  • LESC therapy is a significant advancement in treating blinding ocular surface diseases.
  • Further research into LESC biology will enhance therapeutic potential.
  • Understanding LESCs may inform other adult stem cell applications.